Development of a reproducible porcine model of infected burn wounds.

Severe burns are traumatic and physically debilitating injuries with a high rate of mortality. Bacterial infections often complicate burn injuries, which presents unique challenges for wound management and improved patient outcomes. Currently, pigs are used as the gold standard of pre-clinical models to study infected skin wounds due to the similarity between porcine and human skin in terms of structure and immunological response. However, utilizing this large animal model for wound infection studies can be technically challenging and create issues with data reproducibility. We present a detailed protocol for a porcine model of infected burn wounds based on our experience in creating and evaluating full thickness burn wounds infected with Staphylococcus aureus on six pigs. Wound healing kinetics and bacterial clearance were measured over a period of 27 d in this model. Enumerated are steps to achieve standardized wound creation, bacterial inoculation, and dressing techniques. Systematic evaluation of wound healing and bacterial colonization of the wound bed is also described. Finally, advice on animal housing considerations, efficient bacterial plating procedures, and overcoming common technical challenges is provided. This protocol aims to provide investigators with a step-by-step guide to execute a technically challenging porcine wound infection model in a reproducible manner. Accordingly, this would allow for the design and evaluation of more effective burn infection therapies leading to better strategies for patient care.

BACKGROUND

Burn injuries constitute a major clinical and economic challenge for healthcare systems worldwide. Approximately 11 million burn injuries of varying severity occur annually worldwide leading to 180000 total fatalities as estimated by the World Health Organization [1]. Severe burn wounds cause both physical and psychological trauma resulting in decreased quality of life. Burn injuries interfere with the normal wound healing process and alter immune responses by disrupting the anatomical and immunological barriers to infection [2,3]. Wound sites are frequently infected with drug resistant bacterial strains, such as methicillin-resistant Staphylococcus aureus (MRSA), resulting in high morbidity and mortality [3-5]. Therefore, it is imperative to develop relevant and reproducible pre-clinical models that allow investigators to study complications, such as bacterial infections, occurring as a result of burn injuries and test the development of novel therapeutic approaches that optimize patient outcomes improving the overall standard of care.

The porcine model represents the most relevant animal model to study wound infection due to the similarities between porcine and human skin in structure, immunological response, and healing patterns [6-10]. The stratum corneum thickness, vascularization, keratin types, and extracellular matrix composition of porcine and human skin are similar, presenting similar elastic components that are important in wound healing. However, this type of large animal model presents with unique technical nuances and challenges that can significantly impact the study outcomes and data reproducibility. Unlike small animal studies, the financial costs and personnel effort associated with large animal studies precludes the ability to rapidly optimize protocols or easily increase the number of animals utilized to obtain statistical power. In addition, infection control measures in a large animal setting are very different from small animal models and require additional considerations to ensure personnel safety and limit contamination with infectious agents.

This protocol captures all the details required to conduct a successful large animal infection study including inoculation control, monitoring local and systemic infection during the treatment period and post-mortem characterization, which has been lacking in prior studies [11]. Previously published protocols have evaluated partial and full thickness burn injuries as well as scald burn injuries in a porcine model [12-16]. Superficial and partial thickness wounds extend to the upper and lower layers of dermal tissue [14]. Full thickness wounds, as described in this study, extend beyond the dermal layer into the hypodermis [14]. In a study that analyzed reproducible skin autografting techniques and hypertrophic scar formation in full thickness porcine burn wounds, the device utilized for creating the skin injuries lacked temperature and pressure precision control [17,18]. In this study we utilize a custom device that ensures precise control of the temperature and pressure to enable the creation of reproducible wounds across various animals. This reduces the variability in the depth and the extent of injury to create full thickness burn wounds. Another novel aspect of this protocol is the addition of a step-by-step protocol to achieve a controlled and reproducible infection in porcine burn wounds as well as the evaluation of the surface bacterial load over a period of 4 weeks. While prior studies have used infectious agents in porcine models, the methods fail to describe detailed techniques to achieve uniform inoculation, infection control and output measures including inoculum plating and histopathological evaluation of tissue biopsies that are outlined in this study [11,19,20].

This protocol provides detailed information to implement a porcine model of infected burn wounds and evaluate wound healing and infection parameters. The protocol is based on data collected from performing second-degree, full thickness, circular burn wounds (n = 10 wounds/pig) on the back of female Yorkshire pigs (40–50 kg, n = 6 total animals) followed by inoculation with Staphylococcus aureus (S. aureus). We utilized this particular strain in this study due to the high prevalence of S. aureus associated infections in skin wounds. Wounds were monitored for healing kinetics and bacterial colonization over a period of 27 d (). Enumerated are steps to achieve a standardized porcine wound infection model that can be utilized by investigators to design and test effective therapeutics that treat bacterial infections. This protocol serves as an important resource for pre-clinical testing in a large animal setting prior to testing a drug or a therapeutic in patients suffering from similar injuries and infections in clinical trials.

✓ Staphylococcus aureus RN4220 [21] or S. aureus (American Type Culture Collection, Cat. # ATCC® 25923)

✓ Tryptic soy broth (TSB) (Fisher Scientific, Cat. # R455052)

✓ Luria Bertrani (LB) agar (Fisher Bioreagents, Cat. # BP1425-500)

✓ BBL mannitol salt agar (MSA) (BD Biosciences, Cat. # 211407)

✓ 100 mm square polystyrene Petri dishes (Fisher Scientific, Cat. # FB0875711A)

✓ 14 ml polystyrene round bottom tubes (Corning, Cat. # 352057)

✓ 96 well flat bottom plates (USA Scientific, Cat. # 5665-5161)

✓ Cotton tipped applicators (Medline, Cat. # MDS202000)

✓ Integra™ Miltex™ 3 mm biopsy punches with plunger system (Fisher Scientific, Cat. # 12-460-407)

✓ HistoChoice® MB tissue fixative (Sigma-Aldrich, Cat. # H2904)

✓ Betadine® solution, 7.5% povidone-iodine (Betadine, Cat. # BSO16P)

✓ Triple pack alcohol swab sticks (Medline, Cat. # MDS093810)

✓ Unscented baby wipes (Up & Up, Cat. # PT-24)

✓ Avant gauze non-woven gauze sponges 3” × 3” (Medline, Cat. # NON21334)

✓ TelfaTM Adhesive Island dressing, 4” × 4” (Medtronic, Cat. # COVH7550)

✓ Tincture of benzoin (3M, Cat. # MC1544)

✓ Steri-DrapeTM (3M, Cat. # M1050)

✓ Elastikon® elastic tape (Johnson & Johnson, Cat. # JJ-005175)

✓ Weck Visistat skin stapler 35W (Teleflex, Cat. # W528235)

✓ Weckstat skin staple remover (Teleflex, Cat. # W525980)

✓ Stainless steel scalpel #10 (Medline, Cat. # MDS15210)

✓ Blank stencil sheets, 4 mil mylar 12” × 12” (Stencil Ease, SKU AMY041212-012-M004)

✓ 50 ml centrifuge tubes (Corning, Cat. # 430829)

✓ Natural cork underlayment Roll (QEP, Cat. # 72003Q)

✓ Push pins (Staples, Cat. # 10552)

✓ GENESYS 30 visible spectrophotometer with test-tube holder (Fisher Scientific, Cat. # 14385340 & 14380443)

✓ Labnet mini-incubator (Laboratory Product Sales, Cat. # I-5311-DS)

✓ Custom Burn Instrument: An in house manufactured device with temperature controlled burn head, pressure sensor, and timer (plans available upon request; ). The main components include a thermal device (Wallbrand™ Electric Branding Tools, Hand-held (Wall Lenk Corp., Cat. # WB200), a heat sensor (SOLO Single-Loop Temperature Controller 1/16 DIN; Solo Inc., Cat. # SL4848-RR), a pressure sensor (ProSense Series Panel Meter; Pro·Sense®, Cat. # DPM3-AT-2R-H), and a digital timer (AutomationDirect, Cat. # CTT-1C-A120)

✓ Ekare inSight 3D (eKare Inc., Fairfax, VA)

✓ Iris Surgical Scissors 4½” Straight Stainless (Teleflex, Cat. # 144300)

✓ Adson Tissue Forceps 4¾” (Teleflex, Cat. # 181223)

✓ Metzenbaum Dissecting Scissors (Teleflex, Cat. # 464715)

MATERIALS

Animals

This protocol was approved by the Institutional Animal Care and Use Committee and the Institutional Biosafety Committee of the Cleveland Clinic. Female Yorkshire pigs were purchased from Michael Fanning Farms (Howe, IN). The animals weighed 40–50 kg at the start of the experiments. Animals were housed in the large animal general housing facility for 1 week to acclimatize and transferred to an animal biosafety level 2 (ABSL2) facility during the experiment. Animals were fed 2% to 4% body weight Teklad Pig Grower Diet (#7200, Teklad), given food enrichment at least biweekly, and free access to water. Food was withdrawn 12–24 h prior to anesthesia. Animal health was assessed twice daily by husbandry staff.

Bacterial inoculum preparation

Prepare a fresh bacterial stock plate on selective agar and incubate overnight at 37°C.

Inoculate 4 ml TSB broth with a single S. aureus colony and incubate overnight at 37°C, shaking at 220 rpm.

Measure the optical density at 600 nm (OD600) of the overnight culture using a spectrophotometer.

Inoculate fresh TSB broth with the overnight culture at a 1:10 dilution (0.4 ml overnight culture into 3.6 ml TSB broth) and incubate at 37°C for 1 h at 220 rpm. Measure OD600 of the culture at the start of incubation (0 h).

After 1 h, measure the OD600 of the secondary culture to confirm log phase growth and calculate the CFU/μl (see NOTE (iii) for more detail).

Prepare the inoculum to be added to the wounds in sterile PBS. Calculate the volume of secondary culture required to inoculate each wound with 106 CFU and pellet the bacteria by centrifugation at 1500 rpm for 15 min. Carefully remove the supernatant and resuspend the bacterial pellet in sterile PBS at the desired concentration (e.g., a concentration of 3.3 × 106 CFU/ml to deliver 106 CFU in a volume of 0.3 ml to a 4 cm diameter wound).

Plate the inoculum in duplicate on selective agar plates for confirmation of CFU applied to the wounds. Refer to section 6 for the plating procedure.

TIPS: (i) Set up replicate overnight cultures (e.g., 2–3 cultures) to ensure sufficient bacteria culture for use the following day. (ii) Always prepare excess inoculum (e.g., 4 times the required volume) to facilitate efficient pelleting and ease of administration (Step.1.6).

HINT: An example of inoculum calculation

✓ If OD600 of secondary culture = 0.452 and correlates with 1.94 × 105 CFU/μl based on the growth curve, then 106 CFU = 5.15 μl culture/wound

✓ If creating 10 wounds total, 10 wounds × 5.15 μl/wound = 51.5 μl total

✓ Will need to generate 4 times the calculated inoculum, 51.5 μl × 4 = 206 μl

✓ Centrifuge 206 μl of secondary culture at 1500 rpm for 5 min. Resuspend pellet in 12 ml sterile PBS (0.3 ml/wound × 10 wounds × 4 = 12 ml).

NOTE: (i) The specific bacterial strain used to inoculate the burn wounds may vary depending on the research question and institutional restrictions. Standard microbiological procedures are used for bacterial culture and BSL2 safety procedures are employed for the kanamycin-resistant S. aureus strain used in this protocol. Consult with your local Institutional Biosafety Committee for more information about recommended practices and procedures for handling BSL2 organisms. (ii) Selective agar refers to agar plates with antibiotics to select for the specific bacterial strain (e.g., LB with kanamycin). Selective and differential agar that permits the growth and identification of specific types of bacteria (e.g., MSA for Staphylococcus strain selective growth, fermentation of mannitol by S. aureus turns the colonies yellow). (iii) Prior to the start of an animal experiment, bacterial growth rate, correlation between culture density and CFU and appropriate selective and/or differential media will need to be determined to aid in the calculations utilized for animal inoculation and evaluation of bacterial colonization. (iv) The optimal inoculation of 4 cm wounds is 106 CFU in 0.3 ml volume. The bacterial amount and volume should be scaled proportionally to fit different size burn wounds.

Administration of anesthesia

Sedate the animal with an intramuscular injection of 4.4–6.6 mg/kg of Telazol.

Intubate the pig and place on 1% to 3% isoflurane inhalation to maintain sedation.

Inject 0.01–0.05 mg/kg buprenorphine intramuscularly to control pain during the wounding procedure.

Place a fentanyl transdermal patch (75 μg) on the upper and posterior part of the neck and secure with a small piece of Elastikon® and skin staples (do not staple through patch). Replace every 72 h.

NOTE: (i) To minimize the risk of aspiration during anesthesia, fast the pig overnight with access to only water. (ii) Although transdermal fentanyl is the primary means of pain control during the experiment, its analgesic effect does not start until 12 h post-administration. Buprenorphine is administered to control pain during this 12 h lag time. (iii) The interval between dressing changes (2–3 d) will determine the dose and duration of the fentanyl patch, as it is easier to place and secure during sedation. (iv) If NSAIDs, such as meloxicam or carprofen, are not expected to interfere with experimental outcomes they should be considered for use after the initial burn procedure in consultation with veterinary staff.

Burn wound creation and inoculation

Under anesthesia, shave the back and sides of the pig with an electric razor. Clean off the back with a moist cloth to remove hair before transferring the pig to the operating room.

Position the pig prone on a procedure table covered with disposable, absorbent pads and mark the wound positions using the prepared plastic template and skin marker.

CRITICAL STEP: Pay special attention to the positioning of the pig, as any spine curvature can impact the correct placement of wounds, alter the skin tension of the wounds, and cause variation in the rate of wound healing.

Clean and prepare the burn area using sterile gauze soaked in betadine solution working from the spinal area to the sides. Cover the pig with sterile drapes.

Create burn wounds according to the layout shown in using a controlled pressure and temperature device (). To achieve a full thickness burn on a 45–50 kg Yorkshire pig, set burn temperature to 200°C and apply pressure of 11.9 PSI for 60 s.

Document the baseline wound area by taking photographs of individual wounds with a reference scale.

Allow wounds to cool before adding the bacterial inoculum. Using a p1000 pipette and barrier tips, slowly add 0.3 ml bacterial inoculum dropwise over the surface of the wound and spread it evenly across the wound surface using a sterile cotton swab.

TIP: Prior to the experiment, confirm that the temperature, pressure, and time settings create the depth of wound desired with your burn device using cadaver pig skin ex-vivo.

NOTE: (i) The elbow and the stifle joints should be positioned to align the pig close to a natural position. This positioning should be replicated in future dressing changes (Step 3.2). (ii) Commercial electric branding irons can be used instead of the custom device shown here; however, they will not provide information about pressure applied during burning and may result in more variable wound creation. (iii) The depth of the wound can be determined using histology. In this study, the wound site extended all the way to the hypodermal region indicating a full thickness burn wound () (iv) We found that the eKare inSight 3D system provides quick, accurate, and consistent measurements of wound area. (v) Mix the inoculum gently but thoroughly, before administering, as the bacteria may settle to the bottom of the tube. This creates a uniform suspension such that consistent amounts of bacteria are administered to each wound (Step 3.6). (vi) Position a sterile gauze pad at the lower edge of the wound to prevent any drips during inoculation that would contaminate the skin or work surface (Step 3.6). This is most easily performed with a second person (one to inoculate and the other to hold the gauze).

Wound dressing application

Cover each wound with a 3” × 3” sterile, non-stick gauze pad with the gauze fold positioned medially ().

Apply tincture of benzoin adhesive solution around the gauze pads ().

Cover gauze pad with 4” × 4” TelfaTM dressing and secure with four staples. The staples need to oppose each other to maintain tension on the TelfaTM dressing ().

Apply three long Elastikon® strips to secure the dressings; one along the spine so that it covers the medial portion of the dressing on both sides and the other two on the side of the torso to cover the lateral side of the dressings ().

Staple through Elastikon® strips to further reinforce each TelfaTM bandage ().

Apply Steri-DrapeTM bandage over the entire back. This layer will minimize contamination, even if the underlying gauze collects excessive discharge.

Anchor the Steri-DrapeTM through the addition of Elastikon® strips across the back and wrapping around the shoulders and hips ().

TIPS: (i) One tube of tincture of benzoin is sufficient for two wounds and is most adhesive while wet; therefore, best results occur when the TelfaTM dressing is secured shortly after application of tincture of benzoin. (ii) If the Steri-DrapeTM extends to cover forelimbs or hind limbs, cut the segment behind the forelimb or in front the hind limbs to allow free movement of the limbs.

NOTE: (i) Monitoring the animal at least twice a day to assess for early signs of dressing failure is paramount to the success of the experiment. As wound healing progresses, animals may rub against enclosure walls to either try to remove the dressing, or alleviate itching. Addressing such shortfalls promptly by placing patches of Steri-DrapeTM or reinforcing with Elastikon® is generally enough to keep the dressing intact until the next dressing change. (ii) To minimize incidence of wound dressing failure, the animal must be housed in a cage free of angular protrusions (e.g., screw heads, automated water systems, etc.) that can catch on the bandage while the animal rubs against the wall.

Dressing changes and sample collection

Sedate the pig with an intramuscular injection of Telazol (4.4–6.6 mg/kg). Intubate and maintain anesthesia by 1% to 3% isoflurane inhalation.

Remove the anchoring Elastikon strips and other layers of the dressing using a surgical staple remover.

Carefully clean the skin using baby wipes, working from the outer areas in towards the wounds to remove wound exudate, residual adhesive, and other detritus.

Carefully clean the area adjacent to the wounds with 70% ethanol swabs to aid in visualization of the wound edge and photograph individual wounds.

Collect a sample of bacteria colonizing the wound surface. Wet the tip of a sterile cotton-tipped applicator with the PBS (0.5 ml) in the collection tube. Gently roll the swab over the entire surface of the wound. Return the swab to the collection tube, cap the tube, and place on ice.

Using a 3 mm biopsy punch, collect tissue from each wound and place into labeled containers with fixative (e.g., HistoChoice®) for subsequent paraffin embedding and histological analysis.

Remove necrotic tissue in the third week of the experiment by lifting the wound eschar with sterile Adson forceps and iris scissors to separate the eschar from the wound bed.

NOTE: (i) Culture analysis to quantify CFU should be performed promptly after sample collection for best results. This can be achieved by incorporating a dedicated team member to retrieve and process the samples immediately after collection. (ii) Tissue biopsy samples should be collected from the same region from the separate wounds (Step 5.6). For example, if the wound is a clock face, at one collection point all samples will be taken at the 12 o’clock position. (iii) Make the debridement day consistent (e.g., D17) between experiments, as this significantly alters wound appearance and the wound surface available for viable bacteria quantification (Step 5.7).

Evaluation of bacterial colonization of wounds

In a biosafety cabinet, prepare a sterile 96 well plate with 80 μl sterile PBS in columns 2–12 using a multichannel pipettor ().

Vortex the collection tubes and then transfer 100 μl to the first column of a sterile 96-well plate in duplicate ().

Serially dilute the sample 1:5 across the rows of the plate ().

CRITICAL STEP: Change pipet tips for each dilution (between columns) to prevent bacterial aggregation.

Using a multichannel-pipette, transfer 5 μl of each dilution to the surface of a bacterial plate to create a small spot (). Perform this on duplicate agar plates (e.g., 4 spots total on 2 plates). Start with the lowest dilution (column 12) and work back to the undiluted sample (column 1).

CRITICAL STEP: Change pipette tips between each column during spot plating to prevent bacterial aggregation.

Keep agar plates upright on the benchtop until dry (e.g., the spots are absorbed into the agar), then invert and transfer to a 37°C incubator for growth overnight.

Count the colonies in each spot for each dilution. Total the colonies from the duplicate samples on duplicate plates (4 spots/wound).

Calculate the CFU/wound using the following equation:

TIPS: (i) Label all plates the night before collection to reduce time between sample procurement and plating. (ii) Remove pipet tips from the 3rd and 6th row of the box to facilitate the transfer and serial dilution of samples using this plate set up (Step 6.3). (iii) Skip rows C and F to allow for spacing between samples on the culture plate (Step 6.1).

HINT: An example for CFU calculation if you plated a 1:5 dilution series and the bacteria were counted at the 7th dilution for 4 spots plated in duplicate:

PROCEDURE

Here 62 is the total colonies from 4 spots; 15625 is the dilution factor (7th dilution); 20 is total plated volume (5 μl plated in 4 spots); and 500 μl is the volume of PBS in the collection tube.

NOTE: (i) For any new experiment, the dilution might need to be optimized. A 1:10 and 1:5 dilution series at the initial time points to estimate the bacterial load is recommended. (ii) Agar growth plates must be very dry before spot plating or else the individual 5 μl spots will merge. Either allow the agar plates to dry at room temperature for ~2 d before use or place in a biosafety cabinet with the lids ajar for 2–4 h before use. (iii) Select the lowest dilution with 10–25 discrete colonies to calculate the CFU of the wound. The same dilution does not need to be selected for each wound, as bacterial loads may be very different between treatment groups. (iv) We recommend plating the samples on both non-selective (e.g., LB agar) and selective and/or differential agar plates to assess both the colonization of the strain used to inoculate the wound, as well as any bacteria that may contaminate the wound during dressing changes.

Study termination

Anesthetize the pig and perform final wound imaging and surface bacteria sample collection as described in step 5.

Perform euthanasia by injecting intravenous pentobarbital (100–120 mg/kg) and confirm expiration with the veterinarian before proceeding.

Make a deep circular incision with a surgical scalpel around the wound boundary.

Using Adson forceps to lift the wound edge and deepen the incision through the subcutaneous fat layer using Metzenbaum dissection scissors vertically until encountering the deep fascia (2–3 cm deep). Once at the deep fascia level, turn the direction of the scissors to start dissecting underneath the wound. There should be a clear separation of planes between the adipose tissue and the deep fascia layer.

Place the excised tissue on a cutting board, keeping the wound orientation the same for all wounds. Cut the wound into strips (1–2 cm wide) using dissection scissors.

Pin the central tissue strip on a 2 × 9 cm cork board and place in a 50 ml conical tube filled with HistoChoice® fixative.

Place additional tissue strips into screw cap tubes and freeze for further biochemical/molecular analyses.

Dispose of the animal corpse as a biohazard per institutional guidelines.

NOTE: (i) Changes in skin appearance and temperature immediately after euthanasia can impact the evaluation of wound appearance, measurement of granulation tissue, and viability of bacteria collected from the wound surface. Therefore, these measurements should be performed on a live, anesthetized animal for consistent results. (ii) Ensure the entire tissue piece is immersed in HistoChoice® fixative. Due to tissue thickness, replace HistoChoice® 24 h later and immerse for an additional 24 h to achieve optimum fixation (48 h total fixation time).

ANTICIPATED RESULTS

Bacterial colonization

A total of 60 wounds across 6 animals were inoculated in this study. We achieved successful inoculation of 59 out of the total 60 wounds (success rate = 98.3%). Collection of surface swab samples and biopsies during dressing change procedures provides valuable information about the bacterial load on wound surfaces and in wound beds. In this study, treatment commenced three days after inoculation of wounds to promote the formation of a bacterial biofilm on the wound. Wounds inoculated with 106 CFU/0.3 ml PBS led to an average recovery of 3.5 × 107 CFU/wound on day 3 after biofilm formation. This is a 35-fold increase in bacterial CFU assessed using surface swabs. To more easily track the change in bacterial load in response to treatment, the results are presented as percent change from D3 values. Recovery of viable bacteria from the wound surface increased sharply between D3 to D9 (an average increase of 5 logs), and then precipitously dropped between D13 through D22 (from 100000% to 200% of D3 values) in wounds treated with Aquaphor (control) (). We tested the efficacy of Neosporin, a known antibiotic ointment, against control (Aquaphor) in accelerating bacterial clearance from wounds. Results showed that Neosporin effectively prevented bacterial growth in wounds starting at D6 and continued treatment with the antibiotic maintained an overall low surface bacterial load throughout the period of 27 d (). The density and location of S. aureus in tissue samples were visualized using a modified Gram stain [22] of fixed, paraffin-embedded tissue sections, as the dye stains the peptidoglycan-rich cell wall of the bacteria a dark purple (). Increased surface bacterial load between D3 and D6 correlates with Gram stain visualization of S. aureus initially on the wound surface on D3, followed by localization of S. aureus under the wound eschar at later time points ().

Wound healing kinetics

Wound healing kinetics were evaluated utilizing two methods that include: (1) Histopathology evaluation using a dermis scoring system, and (2) Quantification of wound surface area to assess wound closure over time from wound photographs. To perform these analyses, tissue biopsy samples were collected from each wound once a week for histological staining and photographs of the wounds acquired at each dressing change over a period of 27 d provide a snapshot of the wound healing kinetics in the porcine model.

For histopathology evaluation, H&E stained tissue sections were analyzed and scored using a dermis score for assessment of tissue inflammation (). The dermis score constitutes grading features such as the presence of inflammatory cells, adipocytes, fibroblasts, hair follicles, and collagen fibers on a scale of 0 to 7 [23]. At earlier time points in this study, abundant adipocytes (day 3) and neutrophils (day 10) were observed in the hypodermis, indicative of an inflammatory phase ( and ). However, over time as the wounds healed in the last week of the study, tissues sections revealed the presence of fibroblasts and collagen deposition, indicating that the wound healing progressed to a tissue remodeling phase ().

In order to assess wound closure over time, photographs acquired during the study were utilized to quantify the wound area relative to the baseline area (day 0 wounds). Wound area gradually increased until day 6, followed by a gradual decrease until day 27 (). The percentage of wound closure can also be quantified by subtracting the area of granulation tissue from the original wound area; however, this can only be performed after wound debridement (D17), as the initial eschar masks early granulation tissue (). Damage to the skin tissue surrounding the burn area can also be measured and excluded from wound closure measurements ().

TROUBLESHOOTING

Common issues that could arise and possible solutions to consider are listed in .

1. Experimental design and wound number estimation

1.1. The maximum number of wounds per pig is primarily guided by the total available surface area, burn depth, wound size, and inter-wound distance required for bandaging each wound separately to reduce cross-contamination.

1.2. The available surface area of the specific pig is determined by measuring the length of the spine from the scapula to iliac crest ().

1.3. Circular wounds 4 cm in diameter are applied symmetrically along the length of the spine, 5 cm from the midline, and a minimum of 5 cm between wound edges on the rostral/caudal axis.

1.4. Once the wounding plan is designed, a plastic template can be created to facilitate the even spacing of the wounds ().

1.5. A Yorkshire pig 45–50 kg will have an available length of ~45 cm, permitting 10 circular burn wounds 4 cm in diameter spaced 5 cm apart and 5 cm from the spinal cord.

2. Tissue biopsy collection considerations

2.1. The frequency of tissue sample collection needs to be balanced with the consideration that the accompanying injury may alter wound healing kinetics.

2.2. We mitigated the impact of biopsy wounding by collecting samples once a week and from a similar anatomical location in each wound. Alternately, some studies dedicate wounds for collecting tissue biopsies and do not include these wounds in healing rate measurements.

2.3. Biopsy collection becomes increasingly difficult in the later stages of wound healing and granulation and may result in bleeding during collection. Keep sterile small scissors and fine-tipped forceps ready to grasp the biopsy and separate the sample from the wound bed. Also have sterile gauze ready to place over the biopsy wound and apply firm pressure on the gauze with a finger to stop bleeding.

2.4. Disinfect the forceps and scissors in between wounds to reduce cross-contamination.

2.5. Bleeding during debridement can be controlled by applying firm pressure on the wound using a sterile gauze pad for a few minutes.

3. Evaluation of systemic infection or sepsis

3.1. Blood samples from infected animals can be drawn from an ear vein on days when dressing change is performed to verify if bacterial inoculation of skin wounds is inducing a systemic infection or sepsis.

3.2. Blood cultures can be plated selectively to quantify bacterial growth or sent to a veterinary laboratory for blood cultures (Marshfield Labs, Cleveland, OH). In our experience, we did not observe any signs of systemic infection in the pilot experiments; therefore, we did not continue to routinely draw blood from the animals.

Biosafety considerations

All animal experiments and infectious agent handling must be performed in accordance with institutional and governmental ethics guidelines and regulations. This protocol was approved by the Institutional Animal Care and Use Committee and the Institutional Biosafety Committee of the Cleveland Clinic. A risk assessment must be performed in consultation with the biosafety and veterinary staff to determine the specific work practices to ensure the safety of personnel and animals within the facility. A resource for recommended biosafety practices is the Biosafety in Microbiological and Biomedical Laboratories, 6th edition [24].

Table S1. Histological dermal score system after burn injury.

Figure S1. Custom burn wound device.

Figure S2. Wound creation template.

Figure S3. Wound closure measurement.

Figure S4. Variation in burn wound creation.

Supplementary information

Supplementary information of this article can be found online at https://jbmethods.org/jbm/article/view/379.

Table 1.

Commonly encountered problems, causes, and potential solutions.

Step	Problem	Cause	Solutions
3.2.2	Variation in wound healing rate due to anatomic location	Depth of subcutaneous fat and skin tension varies over the back of a pig and can significantly alter wound healing rates	Randomize treatment and control wounds to oppose each other across the spine, as well as down the back (e.g., do not group all treatments on one side or one position dorsal/caudal)
3.2.4	Variable initial burn size (Supplementary Fig. 4)	Heat radiation from the sides of the thermal head of the burn device or slippage or tissue compression during burn creation can burn the surrounding area	Slowly apply the burn head during initial contact to prevent slipping Place rolled towels under the hips of the pig to reduce flexion of the lower spine while applying pressure Add a cork insulator around the edges of the thermal head to limit heat transfer from the edges
4.7	Dressing tears & loss of bandage integrity	Pigs rubbing against the cage walls to relieve itch or irritation	Achieve adequate pain control through the use of a sustained delivery device (e.g., fentanyl patch) Ensure that the inside of the cage is completely smooth Monitor bandage integrity twice a day & patch immediately Apply a commercially available swine jacket over the top of the dressings
6.1.5	Polymicrobial colonization of wounds	Over the course of the experiment, wounds may become colonized with additional microbes present on the pig skin (especially D22 onward)	Carefully clean skin, use sterile materials, and use good aseptic technique during dressing changes Plate swab samples on non-selective agar (e.g., LB agar) and compare to results from selective agar plates. Contaminating microbes can be identified using standard differential microbiological agars.